vs
Side-by-side financial comparison of BETA Technologies, Inc. (BETA) and Silence Therapeutics plc (SLN). Click either name above to swap in a different company.
Silence Therapeutics plc is the larger business by last-quarter revenue ($15.7M vs $8.9M, roughly 1.8× BETA Technologies, Inc.). Silence Therapeutics plc runs the higher net margin — -14.7% vs -4902.6%, a 4887.9% gap on every dollar of revenue.
Unity Software Inc. is an American video game software development company based in San Francisco. It was founded in Denmark in 2004 as Over the Edge Entertainment and changed its name in 2007. Unity Technologies is best known for the development of Unity, a licensed game engine used to create video games and other applications.
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.
BETA vs SLN — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2024
| Metric | | |
|---|---|---|
| Revenue | $8.9M | $15.7M |
| Net Profit | $-437.2M | $-2.3M |
| Gross Margin | 69.3% | 82.2% |
| Operating Margin | -903.5% | -35.6% |
| Net Margin | -4902.6% | -14.7% |
| Revenue YoY | 190.9% | — |
| Net Profit YoY | -482.5% | — |
| EPS (diluted) | $-9.83 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $8.9M | — | ||
| Q3 24 | $3.1M | — | ||
| Q1 24 | — | $15.7M |
| Q3 25 | $-437.2M | — | ||
| Q3 24 | $-75.1M | — | ||
| Q1 24 | — | $-2.3M |
| Q3 25 | 69.3% | — | ||
| Q3 24 | 61.2% | — | ||
| Q1 24 | — | 82.2% |
| Q3 25 | -903.5% | — | ||
| Q3 24 | -2381.0% | — | ||
| Q1 24 | — | -35.6% |
| Q3 25 | -4902.6% | — | ||
| Q3 24 | -2448.3% | — | ||
| Q1 24 | — | -14.7% |
| Q3 25 | $-9.83 | — | ||
| Q3 24 | $-1.81 | — | ||
| Q1 24 | — | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $687.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $789.9M | $156.8M |
| Total Assets | $1.1B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $687.6M | — | ||
| Q3 24 | $52.2M | — | ||
| Q1 24 | — | — |
| Q3 25 | $789.9M | — | ||
| Q3 24 | $196.1M | — | ||
| Q1 24 | — | $156.8M |
| Q3 25 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-183.4M | $-9.1M |
| Free Cash FlowOCF − Capex | $-209.0M | — |
| FCF MarginFCF / Revenue | -2344.1% | — |
| Capex IntensityCapex / Revenue | 287.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-183.4M | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | $-9.1M |
| Q3 25 | $-209.0M | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
| Q3 25 | -2344.1% | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
| Q3 25 | 287.8% | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BETA
| Commerical Customers | $6.2M | 70% |
| United States Government | $2.7M | 30% |
SLN
Segment breakdown not available.
